Boditech Med Inc. (KOSDAQ:206640)
14,710
+180 (1.24%)
Sep 19, 2025, 3:30 PM KST
Boditech Med Market Cap
Boditech Med has a market cap or net worth of 320.43 billion as of September 19, 2025. Its market cap has decreased by -22.36% in one year.
Market Cap
320.43B
Enterprise Value
283.96B
Revenue
149.40B
Ranking
n/a
PE Ratio
12.59
Stock Price
14,710.00
Market Cap Chart
Since September 1, 2015, Boditech Med's market cap has increased from 28.15B to 320.43B, an increase of 1,038.22%. That is a compound annual growth rate of 27.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 320.43B | -13.11% |
Dec 30, 2024 | 368.76B | -18.12% |
Dec 28, 2023 | 450.36B | 100.01% |
Dec 29, 2022 | 225.17B | -41.09% |
Dec 30, 2021 | 382.21B | -29.94% |
Dec 30, 2020 | 545.55B | 146.19% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.24T |
Celltrion | 37.10T |
ALTEOGEN | 25.28T |
Yuhan | 8,752.85B |
SK Biopharmaceuticals | 8,410.84B |
Peptron | 6,744.58B |
PharmaResearch | 6,431.19B |
ABL Bio | 5,452.05B |